ArticleInvestigative ophthalmology & visual science2025
U1 RNA Detected by Toll-Like Receptor 3 Plays a Role in the Pathogenesis of Pterygium.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Toll-like receptor 3 (TLR3) detects RNA from pterygium epithelial cells (PECs). We previously suggested that pterygium development may be linked to RNA released from abnormally growing PECs: U1 RNA released from ultraviolet B (UVB)-damaged cells may activate TLR3. This study investigated how U1 RNA, polyriboinosinic:polyribocytidylic acid (poly[I:C]), and PEC lysates affect the TLR3 signaling pathway in PECs and conjunctival epithelial cells (CECs). Methods: Human pterygium and ipsilateral pterygium-free conjunctiva from the same patients were used for cell culture and RNA-sequencing analysis. PECs and CECs were cultured, irradiated with UVB, and treated with poly(I:C), PEC lysates, or synthetic U1 RNA. TLR3 and toll/interleukin-1 receptor domain-containing adaptor-inducing interferon-β (TRIF) expression, phosphorylated nuclear factor-kappa B (NF-κB)/NF-κB ratio, IL-6, and IL-8 were evaluated using western blot, quantitative real-time PCR (qPCR), and enzyme-linked immunosorbent assay (ELISA). Cell proliferation was evaluated using water-soluble tetrazolium salt-1 assay. Results: After UVB irradiation, U1, U2, U4, and U6 RNA increased in PECs and CECs, and TLR3 expression increased in PECs. Western blot and qPCR results indicated an increase in TLR3, TRIF, and NF-κB expression in PECs and CECs treated with poly(I:C), UVB-irradiated PEC lysates, or synthetic U1 RNA compared to controls. However, RNase A inhibited this effect in UVB-irradiated PECs. ELISA showed that IL-6 and IL-8 increased in cell groups treated with poly(I:C), UVB-irradiated PEC lysates, or synthetic U1 RNA. Proliferation of PECs was also increased by poly(I:C). Conclusions: Several small noncoding RNAs, whose expression was induced by UVB irradiation, may be a possible novel therapeutic target for pterygium treatment through activation of the TLR3 signaling pathway.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.